Foligraf 150 IU
Available Dosages
| SKU | 1933 |
|---|---|
| Generic For | Follistim AQ |
| Strength | 150 IU |
| Active Ingredient | Recombinat Human |
Out Of Stock
Foligraf 150 IU – Follistim AQ Alternative for Infertility Treatment
Foligraf injection is a medicine formulated for patients with indications like polycystic ovary syndrome, infertility in the female, etc. It contains the active pharmaceutical ingredient called Urofollitropin, which is a purified form of follicle stimulating hormone (FSH). The dosage of medicine is adjusted according to each individual’s response. It starts the growth of ovarian follicles.
Uses of Foligraf
Foligraf is prepared for the treatment of:
- Infertility in female
- Polycystic syndrome
- PCOD
Contraindications
The use of Foligraf is contraindicated in the following conditions:
- Hypersensitivity to Foligraf or other components of the formulation
- Tumors of the pituitary gland and hypothalamus gland.
- Gynecological haemorrhage
- Ovarian enlargement
- Carcinoma of uterine, mammary gland o, and ovary.
- Pregnancy
- Lactation
Side effects:
Foligraf injection has the following side effects:
- Ovarian enlargement
- Dry skin
- Abdominal pain
- Volume depletion
- Headache
- Ovarian cysts
- Stomach cramps
- Bloating
- Vomiting
- Diarrhea
- Redness
- Bruising
- Irritation
- Pain
- Swelling
Medication interaction:
Sometimes medicines are not safe when you take them with other medicines. Using them together can cause severe side effects. Like other drugs, it is possible that Foligraf can affect the working of other drugs and other drugs can affect the mechanism of action of Foligraf. Such drugs are given below:
- Gonadorelin
- Clomiphene
Inform your health care professional about all the medications that you are using during the treatment with Foligraf injection.
Usage instructions
Always read all the instructions given on your prescription paper provided by your health care specialist. Use it in the same way as your health care specialist told you to. Your health care specialist will give you a demonstration to make you understand how to use this injection. He/she will tell you the best dose that will suit your condition. Do not administer more than the recommended amount. In the case of an overdose, call your nearest medical center immediately. There might be a very bad reaction. Try not to inject at your home, prefer going to your health care specialist’s clinic for administration. Always use Foligraf injection under the supervision of a health care professional. Avoid adjusting your doses without consulting with your health care professional. In case you forget to administer Foligraf 75 IU, do not adminster two times to compensate the missed one. Ask your physician for more information.
Storage information
Store the injection in the refrigerator. Do not freeze the medicine. Keep it away from direct heat and light.
What is Recombinant Human FSH and what condition does it treat?
Recombinant Human FSH (follicle-stimulating hormone) is a fertility medication used to treat infertility in both women and men. Foligraf 150 IU contains this bioengineered hormone that mimics the natural FSH your body produces. In women, this reproductive medicine stimulates the ovaries to develop and release eggs, helping treat conditions like anovulation and supporting assisted reproductive techniques such as IVF. For men experiencing infertility due to low sperm production, recombinant human FSH can improve sperm development when combined with other hormone therapies.
How does Recombinant Human FSH work in the body?
Recombinant Human FSH works by binding to FSH receptors on ovarian follicles in women or testicular cells in men, triggering a cascade of reproductive processes. Foligraf 150 IU delivers this synthetic fertility hormone directly into your system, where it stimulates follicle growth and maturation in the ovaries. In female fertility treatment, it encourages multiple follicles to develop, increasing the chances of successful ovulation. For male patients, this gonadotropin hormone supports spermatogenesis by activating Sertoli cells in the testes, which nurture developing sperm cells and improve overall sperm production quality.
How long does Foligraf 150 IU take to work?
Foligraf 150 IU typically begins stimulating follicle development within 7 to 14 days of starting treatment, though individual response varies based on your baseline fertility status. Most women undergoing ovarian stimulation with this recombinant FSH medication will have ultrasound monitoring every few days to track follicle growth. Complete treatment cycles usually span 10 to 14 days before triggering ovulation. For men using Foligraf for sperm production issues, noticeable improvements in sperm parameters generally appear after three to six months of consistent hormone therapy, as the sperm maturation cycle takes approximately 74 days.
When and how should I take Foligraf 150 IU?
Foligraf 150 IU is administered as a subcutaneous injection, typically into the abdomen or thigh, following your fertility specialist's personalized protocol. Women usually begin this recombinant human FSH treatment on day two or three of their menstrual cycle, injecting once daily at the same time each evening. Your doctor will adjust the dosage based on ultrasound monitoring and blood hormone levels. The injection technique is straightforward, and most patients self-administer at home after proper training. Always follow your prescribed schedule precisely, as timing is critical for optimal follicle development in fertility treatment.
Is Foligraf 150 IU safe for long-term use?
Foligraf 150 IU is generally safe for the duration prescribed by fertility specialists, though it's typically used for specific treatment cycles rather than continuous long-term therapy. Most women use this recombinant FSH medication for individual IVF cycles or several months of ovulation induction, with breaks between attempts. Men may use it for extended periods spanning six to eighteen months for sperm production enhancement. Long-term safety studies show recombinant human follicle-stimulating hormone is well-tolerated, though ongoing medical supervision ensures appropriate dosing and monitors for ovarian hyperstimulation syndrome in women or hormonal imbalances in men.
Can I take Foligraf 150 IU with other medicines?
Foligraf 150 IU is often used alongside other fertility medications as part of comprehensive reproductive treatment protocols. This recombinant human FSH product commonly pairs with GnRH agonists, antagonists, or hCG trigger injections in controlled ovarian stimulation. However, certain medications may affect how your body responds to follicle-stimulating hormone therapy. Inform your fertility doctor about all prescriptions, supplements, and herbal products you're taking. Some drugs affecting hormone levels or ovarian function may require dose adjustments. Your specialist will coordinate your complete medication regimen to optimize treatment outcomes while minimizing interaction risks.
How does Foligraf 150 IU compare to similar medicines in its class?
Foligraf 150 IU belongs to the recombinant FSH class of fertility drugs, which are highly purified compared to older urinary-derived gonadotropins. This synthetic follicle-stimulating hormone offers consistent potency and lower risk of allergic reactions than urinary products like Menopur. Compared to other recombinant brands such as Gonal-F or Puregon, Foligraf contains the same active ingredient and demonstrates equivalent efficacy in clinical studies. The main differences lie in delivery devices, available dosage strengths, and pricing. Many fertility specialists consider recombinant human FSH medications interchangeable, with selection often based on patient preference, insurance coverage, and cost considerations.
Is the generic Recombinant Human FSH as effective as branded versions?
Generic recombinant human FSH formulations like Foligraf 150 IU are bioequivalent to branded versions, offering the same therapeutic effectiveness at more affordable prices. These fertility medications contain identical active follicle-stimulating hormone molecules produced through the same biotechnology processes. Regulatory agencies require generic biologics to demonstrate comparable safety, purity, and clinical outcomes to reference products. Numerous studies confirm that generic recombinant FSH preparations produce similar pregnancy rates, follicle development, and hormone responses as premium brands. Many fertility clinics worldwide trust Foligraf and similar generics, allowing patients to access quality reproductive treatment without the higher brand-name costs.
Why do patients choose PremiumRxDrugs for Foligraf 150 IU?
Patients choose PremiumRxDrugs for Foligraf 150 IU because fertility treatments require reliable sourcing, affordability, and discretion—all strengths of this licensed international pharmacy. The platform offers manufacturer-sourced recombinant human FSH at competitive prices, helping reduce the significant financial burden of infertility treatment. With over a decade serving fertility patients worldwide, they've built trust through authentic medications, secure packaging, and dependable delivery to the USA, UK, Australia, Canada, and beyond. Our easy prescription management and reorder system simplifies ongoing treatment cycles, while free shipping options on qualifying orders provide additional savings during expensive reproductive therapy journeys.
What are the common side effects of Recombinant Human FSH?
Common side effects of Recombinant Human FSH include injection site reactions like redness, swelling, or bruising where you administer the fertility medication. Many women experience mild abdominal bloating, breast tenderness, mood changes, or headaches during follicle-stimulating hormone treatment. Some patients report pelvic discomfort as ovaries enlarge with developing follicles. More serious but less common effects include ovarian hyperstimulation syndrome (OHSS), characterized by severe bloating, rapid weight gain, and abdominal pain. Men may experience acne, breast enlargement, or weight gain. Most side effects are temporary and resolve after completing your treatment cycle.
Who should avoid taking Recombinant Human FSH?
Recombinant Human FSH should be avoided by individuals with primary ovarian failure, uncontrolled thyroid or adrenal disorders, or hormone-sensitive tumors of the reproductive organs, breast, or hypothalamus. Women with ovarian cysts unrelated to polycystic ovary syndrome, abnormal uterine bleeding of unknown cause, or ovarian enlargement should not use this fertility medication. Pregnant or breastfeeding women must avoid follicle-stimulating hormone therapy. Men with testicular cancer or hormone-dependent tumors should not receive treatment. Anyone with known hypersensitivity to recombinant proteins or any ingredient in the formulation should choose alternative fertility options under specialist guidance.
Login
Sign Up
Login
Sign Up